Latin America Investor Daily
SEE OTHER BRANDS

Get your fresh news on finance and banking in Latin America

Latin America Investor Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.

Press releases published on May 14, 2025

Nexxen Reports First Quarter 2025 Financial Results

Nexxen Reports First Quarter 2025 Financial Results

Generated record Q1 Contribution ex-TAC and programmatic revenue, driven by 40% year-over-year CTV revenue growth, alongside a 95% year-over-year increase in Adjusted EBITDA Trading structure simplification has driven higher trading volume as well as …

Creative Realities Reports Fiscal 2025 First Quarter Results

Creative Realities Reports Fiscal 2025 First Quarter Results

LOUISVILLE, Ky., May 14, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced its financial results for the …

Altimmune to Participate at Two Upcoming Investor Conferences

Altimmune to Participate at Two Upcoming Investor Conferences

GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the …

PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update

PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update

VERSATILE-003 Phase 3 Site Initiations Underway Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting Conference call and webcast today at 8:00 a.m. Eastern Time PRINCETON, N.J., May 14, 2025 (GLOBE …

Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update

Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update

BETHESDA, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

Stallion Uranium Announces Failure to File Cease Trade Order

Stallion Uranium Announces Failure to File Cease Trade Order

VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) announces that the British Columbia Securities Commission (the "BCSC"), as the principal regulator of …

LAVA Reports First Quarter 2025 Financial Results, Provides Business Update

LAVA Reports First Quarter 2025 Financial Results, Provides Business Update

Focused on evaluation of strategic alternatives, with restructuring and closure of the Netherlands operations Enrollment in LAVA-1266 Phase 1 continues to progress Cash, cash equivalents and short-term investments of $66.6 million as of March 31, 2025 …

Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update

Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update

Imdusiran combination therapy has functionally cured 8 patients with chronic hepatitis B (cHBV) to date, including 2 patients who received no interferon AB-101, oral small-molecule PD-L1 inhibitor, shown generally safe and well-tolerated with evidence of …

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

- Interim data from ENERGY 3 trial highlight INZ-701’s potential to modify disease course in ENPP1 Deficiency, with sustained phosphate increases and favorable safety and immunogenicity profile to date - - ENERGY 3 trial on track for topline data in first …

Erdene Announces Q1 2025 Results and Provides Bayan Khundii Project Update

Erdene Announces Q1 2025 Results and Provides Bayan Khundii Project Update

HALIFAX, Nova Scotia, May 14, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) ("Erdene" or the "Company") is pleased to announce operating and financial results for the quarter ended March 31, 2025, and to provide an update …

[Latest] Global Pharmaceutical Container Market Size/Share Worth USD 189.45 Billion by 2034 at a 6.98% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[Latest] Global Pharmaceutical Container Market Size/Share Worth USD 189.45 Billion by 2034 at a 6.98% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, May 14, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical Container Market Size, Trends and Insights By Product Type (Bottles, Vials …

PussFi Launches $PUSS: Turning Memes into Real-Utility Tokens!

PussFi Launches $PUSS: Turning Memes into Real-Utility Tokens!

DUBAI, United Arab Emirates, May 14, 2025 (GLOBE NEWSWIRE) -- PussFi has officially launched $PUSS, the first-ever meme-tility token (a meme coin with real-world utility), on Steemit, a decentralized social media platform. Built on the Tron blockchain, $ …

Kornit Digital Reports First Quarter 2025 Results

Kornit Digital Reports First Quarter 2025 Results

First quarter revenues of $46.5 million, in line with previous guidance First quarter GAAP net loss of $5.1 million; non-GAAP net income of $0.6 million Continued to generate cash from operations, demonstrating disciplined execution Reported annual …

Crown Crafts Announces Quarterly Cash Dividend

Crown Crafts Announces Quarterly Cash Dividend

GONZALES, La., May 14, 2025 (GLOBE NEWSWIRE) -- Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) announced today that its Board of Directors has declared a quarterly cash dividend on its Series A common stock of $0.08 per share to be paid on July 3, …

Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

- Oxylanthanum carbonate (OLC) New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with PDUFA target action date of June 28, 2025; ongoing commercial planning in preparation for anticipated …

Coppernico Confirms Large-Scale Copper Skarn System and Expands Pipeline of Priority Targets at Sombrero

Coppernico Confirms Large-Scale Copper Skarn System and Expands Pipeline of Priority Targets at Sombrero

VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF) (“Coppernico” or the “Company”), is pleased to report the remaining assay results from its Phase 1 drill program at its Sombrero Project in Peru. …

Calian annonce les résultats du deuxième trimestre

Calian annonce les résultats du deuxième trimestre

(Tous les montants dans le communiqué sont en dollars canadiens.) OTTAWA, Ontario, 14 mai 2025 (GLOBE NEWSWIRE) -- CalianMD Group Ltd. (TSX : CGY), une société qui fournit des solutions essentielles à la mission, axée sur la défense, l’espace, les soins de …

Calian Reports Results for the Second Quarter

Calian Reports Results for the Second Quarter

(All amounts in release are in Canadian dollars) OTTAWA, Ontario, May 14, 2025 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a mission critical solutions company, with a focus on defence, space, healthcare and strategic growth markets, today released …

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

Resolution of CRL Manufacturing issues in progress - Type A meeting requested No clinical safety or efficacy concerns raised by FDA MONTREAL and CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported …

KP Tissue declares a Quarterly Dividend of $0.18 per Common Share

KP Tissue declares a Quarterly Dividend of $0.18 per Common Share

NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICES MISSISSAUGA, Ontario, May 14, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that the Board of Directors has declared a quarterly dividend of $0.18 per common share, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service